logo
The EU targets Russia's energy revenue and shadow fleet with new sanctions over Ukraine war

The EU targets Russia's energy revenue and shadow fleet with new sanctions over Ukraine war

CTV News5 hours ago
BRUSSELS — The European Union approved on Friday a new raft of sanctions against Russia over its war on Ukraine, including a lower oil price cap, a ban on transactions with Nord Stream gas pipelines, and the targeting of more shadow fleet ships, the EU foreign policy chief said.
'The message is clear: Europe will not back down in its support for Ukraine. The EU will keep raising the pressure until Russia ends its war,' Kaja Kallas said in a statement.
Kallas said the measures amount to 'one of its strongest sanctions packages against Russia to date' linked to the war, now in its fourth year. It comes as European countries start to buy U.S. weapons for Ukraine to help the country better defend itself.
Ukrainian President Volodymyr Zelenskyy welcomed the new measures, describing them as a 'timely and necessary' step amid intensified Russian attacks.
'All infrastructure of Russia's war must be blocked,' Zelenskyy said, adding that Ukraine will synchronize its sanctions with the EU and introduce its own additional measures soon.
The European Commission, the EU's executive branch, had proposed to lower the oil price cap from $60 to $45, which is lower than the market price to target Russia's vast energy revenues. The 27 member countries decided to set the price per barrel at just under $48.
The EU had hoped to get major international powers in the Group of Seven countries involved in the price cap to broaden the impact, but conflict in the Middle East pushed up oil prices and the Trump administration could not be brought onboard.
In 2023, Ukraine's Western allies limited sales of Russian oil to $60 per barrel but the price cap was largely symbolic as most of Moscow's crude — its main moneymaker — cost less than that. Still, the cap was there in case oil prices rose.
Oil income is the linchpin of Russia's economy, allowing President Vladimir Putin to pour money into the armed forces without worsening inflation for everyday people and avoiding a currency collapse.
A new import ban was also imposed in an attempt to close a loophole allowing Russia to indirectly export crude oil via a number of non-EU countries.
The EU also targeted the Nord Stream pipelines between Russia and Germany to prevent Putin from generating any revenue from them in future, notably by discouraging would-be investors. Russian energy giant Rosneft's refinery in India was hit as well.
The pipelines were built to carry Russian natural gas to Germany but are not in operation. They were targeted by sabotage in 2022, but the source of the underwater explosions has remained a major international mystery.
On top of that, the new EU sanctions targeted Russia's banking sector, with the aim of limiting the Kremlin's ability to raise funds or carry out financial transactions. Two Chinese banks were added to the list.
The EU has slapped several rounds of sanctions on Russia since Putin ordered his troops into Ukraine in February 24, 2022.
More than 2,400 officials and 'entities' — often government agencies, banks, companies or organizations — have been hit with asset freezes and travel bans.
But each round of sanctions is getting harder to agree, as measures targeting Russia bite the economies of the 27 member nations. Slovakia held up the latest package over concerns about proposals to stop Russian gas supplies, which it relies on.
The last raft of EU sanctions, imposed on May 20, targeted almost 200 ships in Russia's sanction-busting shadow fleet of tankers. On Friday, 105 more ships were blocked from European ports, locks and from ship-to-ship transfers, bringing the total number of vessels now sanctioned to more than 400.
___
Lorne Cook, The Associated Press
Illia Novikov in Kyiv contributed to this report.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

EU to triple travel permit fee to 20 euros
EU to triple travel permit fee to 20 euros

National Post

timean hour ago

  • National Post

EU to triple travel permit fee to 20 euros

Brussels (Belgium) (AFP) — The digital travel permit for foreigners to enter the European Union should cost 20 euros ($23), almost triple the original planned fee, under a proposal published Friday. Article content The adjustment to the yet-to-be implemented ETIAS scheme for visa-exempt nationals comes as the European Commission seeks to boost its financial resources to fund an array of priorities from defence to agriculture. Article content Article content The change reflects inflation and additional operational costs, the commission said. Article content Article content 'It will also bring the cost for a travel authorisation to the EU in line with similar travel authorisation programmes,' the EU's top executive body said. Article content Adopted in 2018, the European Travel Information and Authorisation System (ETIAS) regulation originally envisaged a fee of seven euros. Article content Britain's equivalent, known as ETA, comes with a 16 pound fee ($21), while the United States' ESTA permit costs $21. Article content Obtainable online, the European Union's ETIAS permit will be required for the bloc's 27 countries with the exception of Ireland, as well as for Norway, Iceland, Switzerland and Liechtenstein. Article content The permit, valid for three years, will be required for non-EU nationals from countries whose citizens do not need a visa for short stays in Europe, such as Canada, Britain and the United States. Article content Those aged under 18 or over 70 years will be exempt from the fee. Article content Brussels said the scheme was created to identify security, irregular migration and other risks as well as to facilitate border crossing for regular travellers. Article content But its implementation, which was supposed to go hand-in-hand with a new automated border check system, has suffered from delays. Article content The European Parliament and member states have two months to review the new 20-euro fee, which will enter into effect as soon as ETIAS becomes operational — now expected for the last quarter of 2026. Article content This week the commission proposed a boosted two-trillion-euro long-term budget for 2028-2034, which has already upset some of the EU countries that will have to chip in most of the money. Article content As part of the blueprint, which is subject to negotiation, Brussels said it will seek to raise about 58 billion euros a year collecting money directly through measures like its carbon border tax and a levy on electronic waste.

J&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?
J&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?

Globe and Mail

timean hour ago

  • Globe and Mail

J&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?

Johnson & Johnson JNJ, on its second-quarter conference call, stated that it expects its oncology sales to reach $50 billion by the end of the decade. Oncology, at present, comprises around 27% of J&J's total revenues. Its oncology sales rose 22.3% on an operational basis in the second quarter to $6.3 billion, driven by strong market growth and share gains of key products such as multiple myeloma treatment Darzalex and prostate cancer drug, Erleada. New cancer drugs, such as Carvykti, Tecvayli, Talvey and Rybrevant, plus Lazcluze, contributed significantly to growth as they witnessed strong launches. Though the $50 billion target was well above consensus, J&J seems quite confident in the target, citing strong growth in its marketed cancer drugs and the potential of upcoming launches like TAR-200 in bladder cancer and the subcutaneous formulation of Rybrevant plus Lazcluze for advanced EGFR-mutated non-small cell lung cancer (NSCLC). TAR-200 is under priority review with the FDA for treating non-muscle invasive bladder cancer and is expected to be approved this year. The subcutaneous formulation of Rybrevant plus Lazcluze has been recommended for approval in the EU while it is under review in the United States. Meanwhile, J&J's oncology pipeline has gained strong momentum in the last year and a half, with promising developments in colorectal and head and neck cancers. In this period, J&J had eight proof-of-concept readouts, which led the candidates to move to late-stage pivotal studies across the portfolio. If these pipeline drugs are eventually approved, they can also boost JNJ's oncology sales. In the five years from 2019 to 2024, J&J's oncology sales have doubled from $10.7 billion in 2019 to $20.8 billion in 2024. To achieve the $50 billion target in the next 5-6 years, the company needs to more than double its sales from 2024 levels. Though quite optimistic, the target is not unachievable. Competition in the Oncology Space Other large players in the oncology space are Pfizer PFE, AstraZeneca AZN, Merck MRK and Bristol-Myers. Pfizer boasts a strong portfolio of approved cancer medicines like Xtandi, Lorbrena and the Braftovi-Mektovi combination. The addition of Seagen in 2023 also strengthened its position in oncology by adding four ADCs — Adcetris, Padcev, Tukysa and Tivdak. Pfizer also has a robust pipeline of cancer candidates with a focus on multiple modalities, including small molecules, antibody-drug conjugates (ADCs) and immuno-oncology biologics. For AstraZeneca, oncology sales now comprise around 41% of total revenues. AstraZeneca's strong oncology sales growth is being driven by medicines such as Tagrisso, Lynparza, Imfinzi, Calquence and Enhertu (in partnership with Daiichi Sankyo). AstraZeneca is working on strengthening its oncology product portfolio through label expansions of existing products and progressing oncology pipeline candidates. Merck's key oncology medicines are PD-L1 inhibitor, Keytruda and PARP inhibitor, Lynparza, which it markets in partnership with AstraZeneca. Keytruda, approved for several types of cancer, alone accounts for around 50% of Merck's pharmaceutical sales. Bristol-Myers' key cancer drug is PD-LI1inhibitor, Opdivo, which accounts for around 20% of its total revenues. JNJ's Price Performance, Valuation and Estimates J&J's shares have outperformed the industry year to date. The stock has risen 14.6% in the year-to-date period compared with an increase of 1.5% for the industry. Image Source: Zacks Investment Research From a valuation standpoint, J&J is reasonably priced. Going by the price/earnings ratio, the company's shares currently trade at 14.97 forward earnings, slightly lower than 15.04 for the industry. The stock is also trading below its five-year mean of 15.70. The Zacks Consensus Estimate for 2025 earnings has risen from $10.60 per share to $10.66 over the past 30 days, while that for 2026 has risen from $10.98 to $11.13 over the same timeframe. J&J has a Zacks Rank #2 (Buy) currently. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. 5 Stocks Set to Double Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include Stock #1: A Disruptive Force with Notable Growth and Resilience Stock #2: Bullish Signs Signaling to Buy the Dip Stock #3: One of the Most Compelling Investments in the Market Stock #4: Leader In a Red-Hot Industry Poised for Growth Stock #5: Modern Omni-Channel Platform Coiled to Spring Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%. Download Atomic Opportunity: Nuclear Energy's Comeback free today. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN): Free Stock Analysis Report Johnson & Johnson (JNJ): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis Report Merck & Co., Inc. (MRK): Free Stock Analysis Report

EU to triple travel permit fee to 20 euros
EU to triple travel permit fee to 20 euros

CTV News

time3 hours ago

  • CTV News

EU to triple travel permit fee to 20 euros

Travellers wait in line at the Ottawa International Airport in Ottawa on Thursday, July 3, 2025. THE CANADIAN PRESS/Sean Kilpatrick The digital travel permit for foreigners to enter the European Union should cost 20 euros, almost triple the original planned fee, under a proposal published Friday. The adjustment to the yet-to-be implemented ETIAS scheme for visa-exempt nationals comes as the European Commission seeks to boost its financial resources to fund an array of priorities from defence to agriculture. The change reflects inflation and additional operational costs, the commission said. 'It will also bring the cost for a travel authorisation to the EU in line with similar travel authorisation programmes,' the EU's top executive body said. Adopted in 2018, the European Travel Information and Authorisation System (ETIAS) regulation originally envisaged a fee of seven euros. Britain's equivalent, known as ETA, comes with a 16 pound fee, while the United States' ESTA permit costs US$21. Obtainable online, the European Union's ETIAS permit will be required for the bloc's 27 countries with the exception of Ireland, as well as for Norway, Iceland, Switzerland and Liechtenstein. The permit, valid for three years, will be required for non-EU nationals from countries whose citizens do not need a visa for short stays in Europe, such as Canada, Britain and the United States. Those aged under 18 or over 70 years will be exempt from the fee. Brussels said the scheme was created to identify security, irregular migration and other risks as well as to facilitate border crossing for regular travellers. But its implementation, which was supposed to go hand-in-hand with a new automated border check system, has suffered from delays. The European Parliament and member states have two months to review the new 20-euro fee, which will enter into effect as soon as ETIAS becomes operational -- now expected for the last quarter of 2026. This week the commission proposed a boosted two-trillion-euro long-term budget for 2028-2034, which has already upset some of the EU countries that will have to chip in most of the money. As part of the blueprint, which is subject to negotiation, Brussels said it will seek to raise about 58 billion euros a year collecting money directly through measures like its carbon border tax and a levy on electronic waste.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store